Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The T-complex protein Ring Complex (TRiC), also known as Chaperonin Containing TCP-1 (CCT), is a eukaryotic group II chaperonin responsible for folding newly synthesized proteins. It is a double-ringed barrel structure, with each ring consisting of eight unique but homologous subunits. TRiC uses ATP hydrolysis to facilitate proper protein folding within its central cavity, primarily acting on actin, tubulin, and other select client proteins. It plays a crucial role in proteostasis, preventing protein aggregation, and its dysfunction is linked to diseases such as Huntington’s disease and cancer.
ATP-dependent protein folding within a central cavity, utilizing conformational changes mediated by ATP hydrolysis; does not require a co-chaperonin.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T-complex protein Ring Complex (TRiC).